Experimental browser for the Atmosphere
8. The FDA unveiled a detailed roadmap to phase out, or dramatically reduce, animal testing, allowing companies to submit AI or organoid data instead. For now, this is for monoclonal antibodies targeting non-human pathogens. One small shift, but part of a bigger change in drug safety testing.
May 2, 2025, 4:20 PM
{ "uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5y6e3e26", "cid": "bafyreihosf72qvcvwobrmi2cdm6u6ipdjpisbstvwbwwzdw2yfx22dp4xi", "value": { "text": "8. The FDA unveiled a detailed roadmap to phase out, or dramatically reduce, animal testing, allowing companies to submit AI or organoid data instead. \n\nFor now, this is for monoclonal antibodies targeting non-human pathogens. One small shift, but part of a bigger change in drug safety testing.", "$type": "app.bsky.feed.post", "langs": [ "en" ], "reply": { "root": { "cid": "bafyreif27i7xp4g2yyuhdaucmmhi2vrvk46xkgfeysxkych72qpth2fomu", "uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5vtuc226" }, "parent": { "cid": "bafyreiewrvxgvggrswxc5n6ghpl3khet55r4swlqjwij4xhmxyxmbxcvki", "uri": "at://did:plc:73aicoale2mqwrap63rdzwep/app.bsky.feed.post/3lo7a5y6d4426" } }, "createdAt": "2025-05-02T16:20:35.880Z" } }